Global biopharmaceutical enterprise Pfizer Inc. has formally announced that Chief Financial Officer Dave Denton will step down from his executive... Read more
Tag: #Global Trends
Regulatory turnaround: FDA advisory panel votes unanimously to endorse Moderna’s mRNA flu vaccine
An independent regulatory advisory committee to the U.S. Food and Drug Administration (FDA) has formally endorsed Moderna’s experimental seasonal influenza... Read more
FDA grants expanded indication for Merck’s Capvaxive to include high-risk pediatric cohorts aged 2 to 17
The U.S. Food and Drug Administration (FDA) has formally approved an expanded indication for Merck & Co.’s 21-valent pneumococcal conjugate... Read more
China diaper scandal: Reproductive toxin Formamide detected in leading baby diaper brands
The Economic Information Daily (China) has published a shocking public health investigation revealing that multiple popular baby diaper brands contain... Read more
U.S. Health Department rolls out over $700 million package targeting mental health, substance addiction, and homelessness
United States Health Secretary Robert F. Kennedy Jr. has officially unveiled a comprehensive institutional funding package exceeding $700 million. The... Read more
Objecting plaintiffs file appeal against regulatory ruling on Bayer’s Roundup class-action settlement
Objecting plaintiffs have formally filed a notice of appeal on Wednesday challenging the judicial decision issued by Judge Autrey. The... Read more
GSK and Spero secure regulatory greenlight for Utebzi, the first oral carbapenem antibiotic for complicated UTIs
Four years after sustaining a regulatory rejection in 2022, British pharmaceutical giant GSK and its partner Spero Therapeutics have scored... Read more
Merck & Co. enters $510 million AI drug discovery pact with Stanford spinout Protillion Biosciences
Global biopharmaceutical giant Merck & Co. has finalized a strategic multi-year licensing and research collaboration agreement with Protillion Biosciences. The... Read more
FDA initiates review of Gilead’s once-weekly oral tablet for HIV PrEP application
The U.S. Food and Drug Administration (FDA) has officially commenced its formal regulatory review of Gilead Sciences’ once-weekly oral prescription... Read more









